Additionally, our finding of SREBF1 deactivation is consistent with reports of its downregulation in AD oligodendrocytes, contributing to neurodegeneration through disrupted cholesterol synthesis (Morabito et al., 2021; Mohamed et al., 2018). Here, SREBF1 is linked to Alzheimer disease.